Neuphoria Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NEUP and other ETFs, options, and stocks.About NEUP
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor.
NEUP Key Statistics
Stock Snapshot
The current Neuphoria Therapeutics Inc.(NEUP) stock price is $3.95, with a market capitalization of 21.24M. The stock trades at a price-to-earnings (P/E) ratio of -0.17.
During the trading session on 2026-08-05, Neuphoria Therapeutics Inc.(NEUP) shares reached a daily high of $3.99 and a low of $3.77. At a current price of $3.95, the stock is +4.8% higher than the low and still -1.0% under the high.
Trading volume for Neuphoria Therapeutics Inc.(NEUP) stock has reached 40.9K, versus its average volume of 864.98K.
Over the past 52 weeks, Neuphoria Therapeutics Inc.(NEUP) stock has traded between a high of $21.40 and a low of $3.19.
Over the past 52 weeks, Neuphoria Therapeutics Inc.(NEUP) stock has traded between a high of $21.40 and a low of $3.19.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.